Dabidane

Anticoagulant indicated for the prevention of cerebrovascular accident and systemic embolism and for mortality reduction in patients with non-valvular atrial fibrillation.

Therapeutic Area
Anticoagulant

Active Ingredient
Dabigatrán

Line
Cardiometabolism

Pharmaceutical Forms
75 mg capsules x 30
110 mg capsules x 30
110 mg capsules x 60
150 mg capsules x 30
150 mg capsules x 60

Download Leaflet Descargar